1. Home
  2. ATI vs EXAS Comparison

ATI vs EXAS Comparison

Compare ATI & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ATI Inc.

ATI

ATI Inc.

N/A

Current Price

$147.91

Market Cap

21.6B

Sector

Industrials

ML Signal

N/A

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

N/A

Current Price

$103.34

Market Cap

19.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ATI
EXAS
Founded
1960
1995
Country
United States
United States
Employees
7600
N/A
Industry
Steel/Iron Ore
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.6B
19.7B
IPO Year
1996
2000

Fundamental Metrics

Financial Performance
Metric
ATI
EXAS
Price
$147.91
$103.34
Analyst Decision
Strong Buy
Hold
Analyst Count
8
17
Target Price
$124.25
$86.62
AVG Volume (30 Days)
2.1M
1.8M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
11.76
80.32
EPS
2.85
N/A
Revenue
$4,043,500,000.00
$4,144,000.00
Revenue This Year
$9.41
$15.37
Revenue Next Year
$8.57
$12.41
P/E Ratio
$51.32
N/A
Revenue Growth
N/A
N/A
52 Week Low
$39.23
$38.88
52 Week High
$168.14
$104.02

Technical Indicators

Market Signals
Indicator
ATI
EXAS
Relative Strength Index (RSI) 48.03 55.07
Support Level $76.10 $102.95
Resistance Level $168.14 $103.77
Average True Range (ATR) 5.96 0.31
MACD -2.15 -0.09
Stochastic Oscillator 15.17 35.98

Price Performance

Historical Comparison
ATI
EXAS

About ATI ATI Inc.

ATI Inc supplies specialty metals to various end markets, including aerospace and defense, oil and gas, automotive, and electrical energy, among many others. The company's operating segment includes High-Performance Materials and Components and Advanced Alloys and Solutions. The majority of revenue is from the High-Performance Materials segment. The High-Performance Materials segment is focused on a wide range of high-performance specialty materials, parts, and components for several the majority of end markets, including the aerospace & defense, medical, and energy markets. Geographically, it operates in the United States, China, the United Kingdom, Germany, France, Canada, and Others, the majority is from the United States.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: